These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27183474)

  • 21. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E; Zer Y; Eksi F
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic characterization of multidrug-resistant Pseudomonas aeruginosa strains isolated from pediatric patients associated to biofilm formation.
    Ochoa SA; Cruz-Córdova A; Rodea GE; Cázares-Domínguez V; Escalona G; Arellano-Galindo J; Hernández-Castro R; Reyes-López A; Xicohtencatl-Cortes J
    Microbiol Res; 2015 Mar; 172():68-78. PubMed ID: 25530579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of biofilm formation and antibiotic resistance pattern of Pseudomonas aeruginosa in human and environmental isolates.
    Gholami S; Tabatabaei M; Sohrabi N
    Microb Pathog; 2017 Aug; 109():94-98. PubMed ID: 28549926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the anti-biofilm and antibacterial effects of Juglans regia L. extracts against clinical isolates of Pseudomonas aeruginosa.
    Dolatabadi S; Moghadam HN; Mahdavi-Ourtakand M
    Microb Pathog; 2018 May; 118():285-289. PubMed ID: 29605650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa.
    Chatzimoschou A; Simitsopoulou M; Antachopoulos C; Walsh TJ; Roilides E
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2198-205. PubMed ID: 25645829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro.
    Pye CC; Yu AA; Weese JS
    Vet Dermatol; 2013 Aug; 24(4):446-9, e98-9. PubMed ID: 23738965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effects of pomegranate and rosemary extracts in combination with antibiotics against antibiotic resistance and biofilm formation of Pseudomonas aeruginosa.
    Abu El-Wafa WM; Ahmed RH; Ramadan MA
    Braz J Microbiol; 2020 Sep; 51(3):1079-1092. PubMed ID: 32394240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic resistance in Pseudomonas aeruginosa is associated with decreased fitness.
    Sun Z; Jiao X; Peng Q; Jiang F; Huang Y; Zhang J; Yao F
    Cell Physiol Biochem; 2013; 31(2-3):347-54. PubMed ID: 23485684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.
    Prickett MH; Hauser AR; McColley SA; Cullina J; Potter E; Powers C; Jain M
    Thorax; 2017 Jan; 72(1):40-47. PubMed ID: 27325751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloraminated drinking water does not generate bacterial resistance to antibiotics in Pseudomonas aeruginosa biofilms.
    Jurgens DJ; Sattar SA; Mah TF
    Lett Appl Microbiol; 2008 May; 46(5):562-7. PubMed ID: 18416704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence attributes in Brazilian clinical isolates of Pseudomonas aeruginosa.
    Silva LV; Galdino AC; Nunes AP; dos Santos KR; Moreira BM; Cacci LC; Sodré CL; Ziccardi M; Branquinha MH; Santos AL
    Int J Med Microbiol; 2014 Nov; 304(8):990-1000. PubMed ID: 25127423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation in vitro of the efficacy of colistin methanesulfonate against biofilm-forming multidrug-resistant Pseudomonas aeruginosa (MDRP).
    Marumo K; Komukai D; Hirose M; Nakamura H; Tanaka H; Ugajin K; Nagashima G; Yoshimura A
    J Infect Chemother; 2013 Apr; 19(2):348-51. PubMed ID: 22872187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
    Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
    PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence and mechanisms of amikacin resistance and its association with beta-lactamases in Pseudomonas aeruginosa: a Korean nationwide study.
    Kim JY; Park YJ; Kwon HJ; Han K; Kang MW; Woo GJ
    J Antimicrob Chemother; 2008 Sep; 62(3):479-83. PubMed ID: 18606785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa.
    Kriengkauykiat J; Porter E; Lomovskaya O; Wong-Beringer A
    Antimicrob Agents Chemother; 2005 Feb; 49(2):565-70. PubMed ID: 15673734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to Antibiotics in Plankton and Biofilm Cultures of Pseudomonas aeruginosa Clinical Strains.
    Babushkina IV; Mamonova IА; Ulyanov VY; Gladkova ЕV; Shpinyak SP
    Bull Exp Biol Med; 2021 Dec; 172(2):155-157. PubMed ID: 34853964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure.
    Solé M; Fàbrega A; Cobos-Trigueros N; Zamorano L; Ferrer-Navarro M; Ballesté-Delpierre C; Reustle A; Castro P; Nicolás JM; Oliver A; Martínez JA; Vila J
    J Antimicrob Chemother; 2015 Nov; 70(11):3004-13. PubMed ID: 26260130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity of mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosa.
    Tetz G; Vikina D; Tetz V
    Ann Clin Microbiol Antimicrob; 2016 Mar; 15():19. PubMed ID: 27001074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.